Kolexia
Levigoureux Elise Pharmacien
Levigoureux Elise
Pharmacien
Hôpital Louis Pradel
Bron, France
37 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Dyskinésies Maladie de Parkinson Atrophie multisystématisée Atrophie Synucléinopathies Maladies neuro-inflammatoires Tauopathies Inflammation Maladies neurodégénératives

Collaborateurs

Voir plus
Zimmer Luc
Zimmer Luc
Hôpital Louis Pradel, Bron, France
Bolot-Chauvet Claire
Bolot-Chauvet Claire
Hôpital Louis Pradel, Bron, France
Chaib Sarah
Chaib Sarah
Hôpital Louis Pradel, Bron, France
Lancelot Sophie
Lancelot Sophie
Hôpital Louis Pradel, Bron, France

Industries

Voir plus
Ipsen
1 collaboration(s)
Dernière en 2020
Advanced Accelerator Applications
1 collaboration(s)
Dernière en 2020
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Multimodal imaging study of the 5-HT receptor biased agonist, NLX-112, in a model of L-DOPA-induced dyskinesia.
NeuroImage. Clinical   15 août 2023
Single subanesthetic dose of ketamine produces delayed impact on brain FFDG PET imaging and metabolic connectivity in rats.
Frontiers in neuroscience   13 juillet 2023
Safety and Therapeutic Optimization of Lutetium-177 Based Radiopharmaceuticals.
Pharmaceutics   13 avril 2023
Mise en place d’entretiens pharmaceutiques avant les scintigraphies à l’[123I]-métaiodobenzylguanidine (mIBG)
9e Journées Francophones de Médecine nucléaire - Paris   01 mars 2023
Amino Acid Solutions for Lu-Oxodotreotide Premedication: A Tolerance Study.
Cancers   24 octobre 2022
fMRI exploration of a biased agonist of 5-HT1A receptors to treat levodopa-induced dyskinesia in hemiparkinsonian rats
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 14–16 June 2022, Lille, France   05 juin 2022
Different Alterations of Agonist and Antagonist Binding to 5-HT1A Receptor in a Rat Model of Parkinson's Disease and Levodopa-Induced Dyskinesia: A MicroPET Study.
Journal of Parkinson's disease   31 janvier 2022
A novel biased agonist of 5-HT1A receptors to treat Levodopa-induced dyskinesia? Exploration of the antidyskinetic effects of NLX-112, using [18F]FDG-PET in hemiparkinsonian rats
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 15–16 June 2021, E‐meeting, France   02 juin 2021
Radiochemical purity of technetium-99m-nanocolloid rhenium sulphide is not influenced by heating.
Nuclear medicine communications   20 juin 2019
Serotonin 5-HT Receptor Biased Agonists Induce Different Cerebral Metabolic Responses: A F-Fluorodesoxyglucose Positron Emission Tomography Study in Conscious and Anesthetized Rats.
ACS chemical neuroscience   07 janvier 2019